166 related articles for article (PubMed ID: 23258641)
1. Comparison of transdermal electromotive administration of verapamil and dexamethasone versus intra-lesional injection for Peyronie's disease.
Mehrsai AR; Namdari F; Salavati A; Dehghani S; Allameh F; Pourmand G
Andrology; 2013 Jan; 1(1):129-32. PubMed ID: 23258641
[TBL] [Abstract][Full Text] [Related]
2. A prospective, randomized study using transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease.
Di Stasi SM; Giannantoni A; Stephen RL; Capelli G; Giurioli A; Jannini EA; Vespasiani G
J Urol; 2004 Apr; 171(4):1605-8. PubMed ID: 15017231
[TBL] [Abstract][Full Text] [Related]
3. Verapamil versus saline in electromotive drug administration for Peyronie's disease: a double-blind, placebo controlled trial.
Greenfield JM; Shah SJ; Levine LA
J Urol; 2007 Mar; 177(3):972-5. PubMed ID: 17296390
[TBL] [Abstract][Full Text] [Related]
4. Transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease.
Di Stasi SM; Giannantoni A; Capelli G; Jannini EA; Virgili G; Storti L; Vespasiani G
BJU Int; 2003 Jun; 91(9):825-9. PubMed ID: 12780842
[TBL] [Abstract][Full Text] [Related]
5. Transdermal electromotive multi-drug administration for Peyronie's disease: preliminary results.
Montorsi F; Salonia A; Guazzoni G; Barbieri L; Colombo R; Brausi M; Scattoni V; Rigatti P; Pizzini G
J Androl; 2000; 21(1):85-90. PubMed ID: 10670523
[TBL] [Abstract][Full Text] [Related]
6. The effectiveness of transdermal electromotive administration with verapamil and dexamethasone in the treatment of Peyronie's disease.
Tuygun C; Ozok UH; Gucuk A; Bozkurt IH; Imamoglu MA
Int Urol Nephrol; 2009; 41(1):113-8. PubMed ID: 18592390
[TBL] [Abstract][Full Text] [Related]
7. Transdermal iontophoresis with verapamil and dexamethasone in the acute phase of peyronie's disease. Our experience.
Garrido Abad P; Coloma A; Herranz LM; Jiménez M; Suárez C; Prieto MD; Formoso T; Fernández Arjona M
Arch Esp Urol; 2012 Oct; 65(8):745-51. PubMed ID: 23117682
[TBL] [Abstract][Full Text] [Related]
8. [Transdermal iontophoresis with dexamethasone and verapamil for Peyronie's disease].
Cabello Benavente R; Moncada Iribarren I; de Palacio España A; Hernández Villaverde A; Monzó JI; Hernández Fernández C
Actas Urol Esp; 2005; 29(10):955-60. PubMed ID: 16447593
[TBL] [Abstract][Full Text] [Related]
9. Use of intralesional verapamil to dissolve Peyronie's disease plaque: a long-term single-blind study.
Rehman J; Benet A; Melman A
Urology; 1998 Apr; 51(4):620-6. PubMed ID: 9586617
[TBL] [Abstract][Full Text] [Related]
10. Intralesional injection of the calcium channel blocker Verapamil in Peyronie's disease: A critical review.
Asali M; Asali M
Arch Ital Urol Androl; 2020 Oct; 92(3):. PubMed ID: 33016057
[TBL] [Abstract][Full Text] [Related]
11. A snapshot of intralesional verapamil injection in the treatment of Peyronie's disease today.
Sadagopan A
Andrologia; 2019 Nov; 51(10):e13388. PubMed ID: 31475740
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of vitamin E in the conservative treatment of Peyronie's disease: legend or reality? A controlled study of 70 cases.
Paulis G; Brancato T; D'Ascenzo R; De Giorgio G; Nupieri P; Orsolini G; Alvaro R
Andrology; 2013 Jan; 1(1):120-8. PubMed ID: 23258640
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of intralesional injection of hyaluronic acid compared with verapamil in Peyronie's disease: preliminary results from a prospective, double-blinded, randomized study.
Favilla V; Russo GI; Zucchi A; Siracusa G; Privitera S; Cimino S; Madonia M; Cai T; Cavallini G; Liguori G; D'Achille G; Silvani M; Franco G; Verze P; Palmieri A; Torrisi B; Mirone V; Morgia G
Andrology; 2017 Jul; 5(4):771-775. PubMed ID: 28718527
[TBL] [Abstract][Full Text] [Related]
14. Iontophoresis for treatment of Peyronie's disease.
Riedl CR; Plas E; Engelhardt P; Daha K; Pflüger H
J Urol; 2000 Jan; 163(1):95-9. PubMed ID: 10604323
[TBL] [Abstract][Full Text] [Related]
15. A prospective, randomized, single - blind study comparing intraplaque injection of thiocolchicine and verapamil in Peyronie's Disease: a pilot study.
Toscano L; Rezende MV; Mello LF; Paulillo D; Glina S
Int Braz J Urol; 2016; 42(5):1005-1009. PubMed ID: 24893912
[TBL] [Abstract][Full Text] [Related]
16. Effect of intralesional verapamil for treatment of Peyronie's disease: a randomized single-blind, placebo-controlled study.
Shirazi M; Haghpanah AR; Badiee M; Afrasiabi MA; Haghpanah S
Int Urol Nephrol; 2009; 41(3):467-71. PubMed ID: 19199072
[TBL] [Abstract][Full Text] [Related]
17. Open preliminary randomized prospective clinical trial of efficacy and safety of three different verapamil dilutions for intraplaque therapy of Peyronie's disease.
Cavallini G; Modenini F; Vitali G
Urology; 2007 May; 69(5):950-4. PubMed ID: 17482941
[TBL] [Abstract][Full Text] [Related]
18. Intralesional verapamil for the treatment of Peyronie's disease: a review.
Levine LA; Estrada CR
Int J Impot Res; 2002 Oct; 14(5):324-8. PubMed ID: 12454681
[TBL] [Abstract][Full Text] [Related]
19. Intralesional verapamil injection for the treatment of Peyronie's disease.
Levine LA; Merrick PF; Lee RC
J Urol; 1994 Jun; 151(6):1522-4. PubMed ID: 8189561
[TBL] [Abstract][Full Text] [Related]
20. Oral propionyl-l-carnitine and intraplaque verapamil in the therapy of advanced and resistant Peyronie's disease.
Cavallini G; Biagiotti G; Koverech A; Vitali G
BJU Int; 2002 Jun; 89(9):895-900. PubMed ID: 12010235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
